Henry C. Lin, MD: Clinical Trials

2 trials sponsored by Henry C. Lin, MD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 1 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1
Phase 11Unknown 1

Follow Henry C. Lin, MD: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bacterial Overgrowth Associated With Chronic Multisymptom Illness Complex
Lactulose Breath Test, Rifaximin, Placebo - Gulf War Syndrome
Phase 1UnknownHenry C. Lin, MD2102009-04-012013-05-01
Does Small Intestinal Bacterial Overgrowth Contribute to Functional Dyspepsia
Rifaximin, Lactulose Breath Test, Placebo - Functional Dyspepsia, Small Intestinal Bacterial Overgrowth
Not applicableCompletedHenry C. Lin, MD552007-08-012012-10-24

Conditions studied

Persian Gulf Syndrome (1)

Interventions

Rifaximin (2)

Countries

United States (2)

Top investigators

Henry C Lin, MD (1)

NIH funding

R21DK078101 (1)